The hopes of the mesenchymal stem cells in regenerative medicine;Les espoirs des cellules souches mésenchymateuses en médecine réparatrice

Transfusion Clinique et Biologique

Volumn 14, Issue 1, 2007, Pages 120-126

  Bourin, P ^a   Gadelorge, M ^a  

^a ETABLISSEMENT FRANÇAIS DU SANG   (France)

Author keywords

Adipose tissue; Bone marrow; Cell culture; Good manufacturing practice; Mesenchymal stem cells; Regenerative medicine

Indexed keywords

CELL CULTURE; CLINICAL PRACTICE; IMMUNOMODULATION; MESENCHYMAL STEM CELL; REGENERATIVE MEDICINE; SHORT SURVEY;

ADIPOSE TISSUE; BONE MARROW CELLS; CELL CULTURE TECHNIQUES; CELL DIFFERENTIATION; FIBROBLASTS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMATOPOIETIC STEM CELLS; HUMANS; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STEM CELLS; REGENERATION;

EID: 34249871369     PISSN: 12467820     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tracli.2007.03.012     Document Type: Short Survey

References (52)

1. Owen M., and Friedenstein A.J. Stromal stem cells: marrow-derived osteogenic precursors. Ciba Found Symp 136 (1988) 42-60
2. Friedenstein A.J., Chailakhyan R.K., and Gerasimov U.V. Bone marrow osteogenic stem cells: in vitro cultivation and transplantation in diffusion chambers. Cell Tissue Kinet 20 (1987) 263-272
3. Lennon D.P., Haynesworth S.E., Bruder S.P., Jaiswal N., and Caplan A.I. Human and animal mesenchymal progenitor cells from bone marrow: identification of serum for optimal selection and proliferation. In Vitro Cell Dev Biol 32 (1996) 602-611
4. Pittenger M.F., Mackay A.M., Beck S.C., et al. Multilineage potential of adult human mesenchymal stem cells. Science 284 (1999) 143-147
5. Galmiche M.C., Koteliansky V.E., Briere J., Herve P., and Charbord P. Stromal cells from human long-term marrow cultures are mesenchymal cells that differentiate following a vascular smooth muscle differentiation pathway. Blood 82 (1993) 66-76
6. Moreau I., Duvert V., Caux C., et al. Myofibroblastic stromal cells isolated from human bone marrow induce the proliferation of both early myeloid and b-lymphoid cells. Blood 82 (1993) 2396-2405
7. Charbord P. Le micro-environnement médullaire chez l'homme normal et pathologique. Hématologie 4 (1998) 29-40
8. Majumdar M.K., Thiede M.A., Haynesworth S.E., Bruder S.P., and Gerson S.L. Human marrow-derived mesenchymal stem cells (MSCs) express hematopoietic cytokines and support long-term hematopoiesis when differentiated toward stromal and osteogenic lineages. J Hematother Stem Cell Res 9 (2000) 841-848
9. Sensebe L., Li J., Lilly M., et al. Nontransformed colony-derived stromal cell lines from normal human marrows. 1. Growth requirement and myelopoiesis supportive ability. Exp Hematol 23 (1995) 507-513
10. Yamaguchi M., Hirayama F., Kanai M., et al. Serum-free cocluture system for ex vivo expansion of human cord blood primitive progenitors and SCID mouse-reconstituting cells using human bone marrow primary stromal cells. Exp Hematol 29 (2001) 174-182
11. Gronthos S., Graves S.E., Ohta S., and Simmons P.J. The STRO-1(+) fraction of adult human bone marrow contains the osteogenic precursors. Blood 84 (1994) 4164-4173
12. Deschaseaux F., and Charbord P. Human marrow stromal Precursors are alpha1 integrin subunit-positive. J Cell Physiol 184 (2000) 319-325
13. Boiret N., Rapatel C., Veyrat-Masson R., et al. Characterization of nonexpanded mesenchymal progenitor cells from normal adult human bone marrow. Exp Hematol 33 (2005) 219-225
14. Ishida T., Inaba M., Hisha H., et al. Requirement of donor-derived stromal cells in the bone marrow for successful allogeneic bone marrow transplantation. Complete prevention of recurrence of autoimmune diseases in MRL/MP-lpr/lpr mice by transplantation of bone marrow plus bones (stromal cells) from same donor. J Immunol 152 (1994) 3119-3127
15. Bartholomew A., Sturgeon C., Siatskas M., et al. Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo. Exp Hematol 30 (2002) 42-48
16. Uccelli A., Moretta L., and Pistoia V. Immunoregulatory function of mesenchymal stem cells. Eur J Immunol 36 (2006) 2566-2573
17. Zuk P.A., Zhu M., Mizuno H., et al. Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Eng 7 (2001) 211-228
18. Puissant B., Barreau C., Bourin P., et al. Immunomodulatory effect of human adipose tissue-derived adult stem cells: comparison with bone marrow mesenchymal stem cells. Br J Haematol 129 (2005) 118-129
19. Planat-Bénard V., Silvestre J.S., Cousin B., et al. Plasticity of human adipose lineage cells toward endothelial cells: physiological and therapeutic perspectives. Circulation 109 (2004) 656-663
20. Planat-Bénard V., Menard C., André M., et al. Spontaneous cardiomyocyte differentiation from adipose tissue stroma cells. Circ Res 94 (2004) 223-229
21. Mitchell J.B., McIntosh K., Zvonic S., et al. Immunophenotype of human adipose-derived cells: temporal changes in stromal-associated and stem cell-associated markers. Stem Cells 24 (2006) 376-385
22. Bieback K., Kern S., Kluter H., and Eichler H. Critical parameters for the isolation of mesenchymal stem cells from umbilical cord blood. Stem Cells 22 (2004) 625-634
23. Lee O.K., Kuo T.K., Chen W.M., Lee K.D., Hsieh S.L., and Chen T.H. Isolation of multipotent mesenchymal stem cells from umbilical cord blood. Blood 103 (2004) 1669-1675
24. Caplan A.I. Mesenchymal stem cells: cell-based reconstructive therapy in orthopedics. Tissue Eng 11 (2005) 1198-1211
25. Healey J.H., Zimmerman P.A., Jessop A.B., McDonell J.M., and Lane J.M. Percutaneous bone marrow grafting of delayed union and non union in cancer patients. Clin Orthop 256 (1990) 280-285
26. Hernigou P., and Beaujean F. Treatment of osteonecrosis with autologous bone marrow grafting. Clin Orthop 405 (2002) 14-23
27. Hernigou P., and Beaujan F. Pseudarthroses traitées par greffe percutanée de moelle osseuse autologue. Rev Chir Orthop 83 (1997) 495-504
28. Hernigou P., Poignard A., Beaujean F., and Rouard H. Percutaneous autologous bone-marrow grafting for nonunions. Influence of the number and concentration of progenitor cells. J Bone Joint Surg Am 87 (2005) 1430-1437
29. Warnke P.H., Springer I.N., Wiltfang J., et al. Growth and transplantation of a custom vascularised bone graft in a man. Lancet 364 (2004) 766-770
30. Quarto R., Mastrogiacomo M., Cancedda R., et al. Repair of large bone defects with the use of autologous bone marrow stromal cells. N Engl J Med 344 (2001) 385-386
31. Vacanti C.A., Bonassar L.J., Vacanti M.P., and Shufflebarger J. Replacement of an avulsed phalanx with tissue-engineered bone. N Engl J Med 344 (2001) 1511-1514
32. Horwitz E.M., Prockop D.J., Gordon P.L., et al. Clinical responses to bone marrow transplantation in children with severe osteogenesis imperfecta. Blood 97 (2001) 1227-1231
33. Horwitz E.M., Prockop D.J., Fitzpatrick L.A., et al. Transplantability and therapeutic effects of bone marrow-derived mesenchymal cell in children with osteogenesis imperfecta. Nature Med 5 (1999) 309-313
34. Horwitz E.M., Gordon P.L., Koo W.K.K., et al. Isolated allogeneic bone marrow-derived mesenchymal cells engraft and stimulate growth in children with osteogenesis imperfecta: implications for cell therapy of bone. Proc Natl Acad Sci USA 99 (2002) 8932-8937
35. Whyte M.P., Kurtzberg J., McAlister W.H., et al. Marrow cell transplantation for infantile hypophosphatasia. J Bone Miner Res 18 (2003) 624-636
36. Koç O.N., Gerson S.L., Cooper B.W., et al. Rapid hematopoietic recovery after coinfusion of autologous-blood stem cells and cultured-expanded marrow mesenchymal stem cells in advanced breast cancer patients receiving high-dose chemotherapy. J Clin Oncol 18 (2000) 307-316
37. Lazarus H.M., Koc O.N., Devine S.M., et al. Cotransplantation of HLA-identical sibling culture-expanded mesenchymal stem cells and hematopoietic stem cells in hematologic malignancy patients. Biol Blood Marrow Transplant 11 (2005) 389-398
38. Le Blanc K., Rasmusson I., Sundberg B., et al. Treatment of severe acute graft-versus-host disease with third party haploindentical mesenchymal stem cells. Lancet 363 (2004) 1439-1441
39. Lee S.T., Jang J.H., Cheong J.W., et al. Treatment of high-risk acute myelogenous leukaemia by myeloablative chemoradiotherapy followed by co-infusion of T cell-depleted haematopoietic stem cells and culture-expanded marrow mesenchymal stem cells from a related donor with one fully mismatched human leucocyte antigen haplotype. Br J Haematol 118 (2002) 1128-1131
40. Fang B., Song Y.P., Liao L.M., Han Q., and Zhao R.C. Treatment of severe therapy-resistant acute graft-versus-host disease with human adipose tissue-derived mesenchymal stem cells. Bone Marrow Transplant 38 (2006) 389-390
41. Shake J.G., Gruber P.J., Baumgartner W.A., et al. Mesenchymal stem cell implantation in a swine myocardial infarct model: engraftment and functionnal effects. Ann Thorac Surg 73 (2002) 1919-1926
42. Strauer B.E., Brehm M., Zeus T., et al. Repair of infarcted myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans. Circulation 106 (2002) 1913-1918
43. Assmus B., Schächinger V., Teupe C., et al. Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction (TOPCARE-AMI). Circulation 106 (2002) 3009-3017
44. Chen S.L., Fang W.W., Ye F., et al. Effect on left ventricular function of intracoronary transplantation of autologous bone marrow mesenchymal stem cell in patients with acute myocardial infarction. Am J Cardiol 94 (2004) 92-95
45. Sekiya I., Larson B.L., Smith J.R., Pochampally R.R., Cui J.G., and Prockop D.J. Expansion of human adult stem cells from bone marrow stroma: conditions that maximize the yields of early progenitors and evaluate their quality. Stem Cells 20 (2002) 530-541
46. Muraglia A., Cancedda R., and Quarto R. Clonal mesenchymal progenitors from human bone marrow differentiate in vitro according to a hierarchical model. J Cell Sci 113 (2000) 1161-1166
47. Rubio D., Garcia-Castro J., Martin M.C., et al. Spontaneous human adult stem cell transformation. Cancer Res 65 (2005) 3035-3039
48. Lennon D.P., Haynesworth S.E., Young R.G., Dennis J.E., and Caplan A.I. A chemically defined medium supports in vitro proliferation and maintains the osteochondral potential of rat marrow-derived mesenchymal stem cells. Exp Cell Res 219 (1995) 211-222
49. Tuschong L., Soenen S.L., Blaese R.M., Candotti F., and Muul L.M. Immune response to fetal calf serum by two adenosine deaminase-deficient patients after T cell gene therapy. Hum Gene Ther 13 (2002) 1605-1610
50. Kocaoemer A, Kern S, Klueter H, Bieback K. Human AB-serum as well as thrombin-activated platelet-rich-plasma are suitable alternatives to fetal calf serum for the expansion of mesenchymal stem cells from adipose tissue. Stem Cells. 2007 Jan 25; [Epub ahead of print].
51. Martin I., Muraglia A., Campanile G., Cancedda R., and Quarto R. Fibroblast growth factor-2 supports ex vivo expansion and maintenance of osteogenic precursors from human bone marrow. Endocrinology 138 (1997) 4456-4462
52. Bianchi G., Banfi A., Mastrogiacomo M., et al. Ex vivo enrichment of mesenchymal cell progenitors by fibroblast growth factor 2. Exp Cell Res 287 (2003) 98-105